Side-by-side comparison of AI visibility scores, market position, and capabilities
New Delhi India YC W20 digital lending NBFC at INR 800Cr ($96M) revenue and INR 68Cr profit FY2024; $431M total at $800M valuation with INR 13,000Cr+ cumulative disbursals preparing for IPO competing with KreditBee.
Stashfin is a New Delhi, India-based digital lending fintech and NBFC (Non-Banking Financial Company) — backed by Y Combinator (W20) with $431 million in total funding (including significant debt financing) at an $800 million valuation as of June 2022 — providing instant personal loans, credit lines, and consumer credit products to underserved segments in India through a mobile-first digital lending platform. In FY2024, Stashfin generated INR 800 crore ($96 million) in revenue, INR 68 crore in net profit, and INR 2,000 crore in assets under management (AUM), while disbursing over INR 3,500 crore ($420 million) in loans in 2024 alone — with cumulative disbursals exceeding INR 13,000 crore ($1.56 billion) since inception. Founded in 2016, Stashfin is reportedly preparing for an IPO.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.